Holen Sie sich die Stockscreener-App
1.91
3.54%
-0.07
Schlusskurs vom Vortag:
$1.98
Offen:
$2.01
24-Stunden-Volumen:
123.56K
Relative Volume:
1.06
Marktkapitalisierung:
$75.55M
Einnahmen:
$63.15M
Nettoeinkommen (Verlust:
$-40.30M
KGV:
-1.1437
EPS:
-1.67
Netto-Cashflow:
$-44.47M
1W Leistung:
-4.98%
1M Leistung:
+15.76%
6M Leistung:
-28.46%
1J Leistung:
-57.84%
1-Tages-Spanne:
$1.5977
$2.1299
1-Wochen-Bereich:
$1.5977
$2.1859
52-Wochen-Spanne:
$0.8645
$4.78
Tela Bio Inc Stock (TELA) Company Profile
Firmenname
Tela Bio Inc
Sektor
Branche
Telefon
484-320-2930
Adresse
1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA
Vergleichen Sie TELA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TELA
Tela Bio Inc
|
1.91 | 79.51M | 63.15M | -40.30M | -44.47M | -1.67 |
|
ABT
Abbott Laboratories
|
125.73 | 228.77B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.16 | 153.09B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
395.15 | 149.27B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
91.65 | 114.31B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.30 | 45.06B | 5.54B | 4.18B | 623.10M | 7.00 |
Tela Bio Inc Stock (TELA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-21 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-05-31 | Eingeleitet | Lake Street | Buy |
| 2019-12-03 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-12-03 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2019-12-03 | Eingeleitet | Jefferies | Buy |
| 2019-12-03 | Eingeleitet | Piper Jaffray | Overweight |
Alle ansehen
Tela Bio Inc Aktie (TELA) Neueste Nachrichten
TELA Bio to Announce Q2 2025 Results with Live Webcast and Corporate Update - MyChesCo
What drives TELA Bio Inc. stock priceDynamic profit expansion - jammulinksnews.com
TELA Bio Inc. Stock Analysis and ForecastTremendous growth opportunities - jammulinksnews.com
TELA Bio to Announce Second Quarter 2025 Financial Results - GlobeNewswire
Medical Tech Leader TELA Bio Sets Q2 Earnings Date: Key Financial Results Coming August 11 - Stock Titan
Is TELA Bio Inc. a good long term investmentTriple-digit profit margins - Autocar Professional
What analysts say about TELA Bio Inc. stockLightning-fast growth - PrintWeekIndia
Will TELA Bio Inc. stock benefit from AI tech trendsShort Squeeze Radar - Newser
How TELA Bio Inc. stock performs during market volatilityFree Stock Market Group - beatles.ru
Why TELA Bio Inc. stock is on top investor watchlists3x Return Stock Radar - Newser
Further Upside For TELA Bio, Inc. (NASDAQ:TELA) Shares Could Introduce Price Risks After 32% Bounce - simplywall.st
Why TELA Bio Inc. stock attracts strong analyst attentionMarket Timing Advice - Newser
What makes TELA Bio Inc. stock price move sharplyFree Exclusive Stock Market Insights - Newser
TELA Bio (NASDAQ:TELA) Shares Down 5.4% – Here’s What Happened - Defense World
TELA Bio's Growth Crossroads: Can Revenue Momentum Outweigh Persistent Losses? - AInvest
Universal Media Group (OTCMKTS:UMGP) vs. TELA Bio (NASDAQ:TELA) Critical Comparison - Defense World
Wall Street Zen Downgrades TELA Bio (NASDAQ:TELA) to Sell - Defense World
Millennium Management LLC Has $183,000 Position in TELA Bio, Inc. (NASDAQ:TELA) - Defense World
TELA Bio Launches OviTex Reinforced Tissue Matrix for Hernia Repair in Europe - MSN
TELA Bio Welcomes Jim Hagen with Strategic Equity Grant - MSN
Finanzdaten der Tela Bio Inc-Aktie (TELA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.64%
0.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):